Ray Gani

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

Sonja Sorensen, Ray Gani, Paul Robinson et al. · Heart · 2012 · 127 citations · Full text

Cost-Effectiveness Analyses of Natalizumab (Tysabri®) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK

Ray Gani, Gavin Giovannoni, David O. Bates et al. · PharmacoEconomics · 2008 · 103 citations

Disease Management, Clinical Effectiveness, Other Disease-modifying Therapies +7

Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium

Robert Hettle, Hanne Wouters, Jon G. Ayres et al. · Respiratory Medicine · 2012 · 25 citations

Cost-utility Analysis, Healthcare Value, Health Policy +11

<p>The Cost-Effectiveness of Universal Varicella Vaccination in Italy: A Model-Based Assessment of Vaccination Strategies</p>

Chiara Azzari, Vincenzo Baldo, Sandro Giuffrida et al. · ClinicoEconomics and Outcomes Research · 2020 · 24 citations · Full text

Economic analyses comparing tiotropium with ipratropium or salmeterol in UK patients with COPD

Ray Gani, Jane Griffin, Steve Kelly et al. · Primary Care Respiratory Journal · 2010 · 22 citations · Full text

Pulmonary Care, Health Economics, Outcomes Research +4